 |
|
|
| |
Clinical characteristics used for machine learning identification of fast progressors among patients with NASH
|
| |
| |
AASLD 2020 Nov 11-16
Brenda Reinhart1, Matt Docherty2, Maria-Magdalena Balp3, Andreas Tietz3, Jennifer Cai4, Sanchita Porwal5, Carolle Kinyua6, Marcos C Pedrosa3, Jorn M Schattenberg7
1ZS Associates, Zurich, Switzerland; 2ZS Associates, Princeton, USA; 3Novartis Pharma AG, Basel, Switzerland; 4Novartis Pharmaceuticals Inc, East Hanover, USA; 5ZS Associates, London, UK; 6Novartis South Africa (Pty) Ltd, Waterfall City, South Africa; 7Department of Medicine, University Medical Center Mainz, Germany
|
| |
|
|
|
|
|
